Last reviewed · How we verify

NCT06966622

Comparison of Retinal Damage in ICL Implantation Using 3D Visualization System vs. Microscope

Not yet recruiting NA Last updated 8 August 2025
What this trial tests

NA trial testing 3D visualization system with coaxial illumination in High Myopia in 40 participants. Not yet recruiting.

Timeline
25 August 2025
Primary endpoint
30 November 2025
31 May 2026

Quick facts

Lead sponsorFuzhou Eye Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment40
Start date25 August 2025
Primary completion30 November 2025
Estimated completion31 May 2026

Drugs / interventions tested

Conditions studied

Sponsor

Fuzhou Eye Hospital

Who can join

Adults 18 to 40, any sex, with High Myopia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Implantable collamer lens (ICL) implantation is considered one of the most effective surgical treatments for high myopia. The procedure primarily involves adjusting the position of the ICL within the eye. However, precise calculation of the ICL optical power may cause the surgical light source to remain focused on the macular area during this process, potentially leading to iatrogenic light-induced damage. Theoretically, the combination of a 3D visualization surgical system and coaxial illumination technology can reduce the illumination intensity and decrease iatrogenic light damage. This study aims to compare the retinal physiological changes in patients undergoing ICL surgery through 3D visualization surgical system with coaxial illumination versus a traditional microscope with standard illumination.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for High Myopia

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06966622.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing